AstraZeneca PLC got a ratings cut from Standard & Poor's Monday, but the drug maker's U.S. depositary shares didn't seem worse for wear as they trickled up on a generally down day for Wall Street.
http://blogs.marketwatch.com/health-exchange/2013/04/08/opening-hour-astrazeneca-rating-cut-anacor-gets-grant-from-gates/
http://blogs.marketwatch.com/health-exchange/2013/04/08/opening-hour-astrazeneca-rating-cut-anacor-gets-grant-from-gates/
